中文
On the morning of August 20th, Park Yongji, the head of operations in South China of Yangtze River Pharmaceutical Group, and Liu Zhiqiang, director of the research institute of Guangzhou Hairui Pharmaceutical Co., Ltd. (hereinafter referred to as “Hai Rui Pharmaceutical”), and others went to the Shenzhen Bay Laboratory for research and exchange. Li Zigang, executive director of Shenzhen Bay Laboratory's Pingshan Biomedical R&D and Transformation Center (hereinafter referred to as "Pingshan Center"), and Chen Jiean, Minister of Scientific Research, called Yin Feng, participated in the forum.
At the meeting, Executive Director Li Zigang extended a warm welcome to the Yangtze River Pharmaceutical Group and his party. Cheng Jiefeng, Head of Business Development of Hairui Pharmaceutical Research Institute, introduced the group’s development history, quality indicators, R&D team and core products (such as Weisu Granules, Blue Qin oral liquid) and other situations.
Dr. Chen Jiean from Pingshan Center introduced the construction goals and history of Shenzhen Bay Laboratory and Pingshan Center, foreign cooperation and research teams, and discussed with Executive Director Li Zigang on the development of new anti-tumor targeted drugs and joint drug research, alternative drug development and Research and other aspects introduce in detail the team strength and technical advantages of the Pingshan Center in chemical and biological drug research.
In the end, the two parties made detailed communication on drug R&D ideas, drug screening, platform technology, chemical and biological drugs from R&D to industrialization, and expressed their cooperation intentions in scientific research projects and industrialization.
Written| Pingshan Biomedical R&D and Transformation Center
Edit|For nothing
